| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departamento de Biologia Funcional, Facultad de Medicina, Universidad de Oviedo, 33006-Oviedo [L. M. S., C. L-O.]; Servicio de Cirugia General, Hospital de Jove, Gijón [F. V.]; and Servicio de Ginecologia, Hospital Central de Asturias, Oviedo [I. D-I.], Spain
The protein composition of breast secretions from 99 premenopausal women with benign or malignant breast diseases and from 70 control women without breast pathologies has been studied by using polyacrylamide gel electrophoresis. These fluids have been classified into two types according to their major polypeptide components. Type I fluids are defined by three major distinctive bands at Mr 44,000, 24,000, and 17,000, while those designated Type II present distinctive bands at Mr 80,000, 15,000, and 14,000. Amino acid sequencing and immunoblotting analysis demonstrated that proteins in Type I secretions correspond to Zn-
2-glycoprotein, apolipoprotein D, and gross cystic disease fluid protein-15, while those from Type II fluids have been identified as lactoferrin, lysozyme, and -lactalbumin. Most women (93%) without breast pathology and most patients (88%) with benign diseases had secretions with a Type I polypeptide pattern. By contrast, a large percentage (57%) of secretions from women with breast carcinoma presented a Type II protein pattern. Further studies with a large number of women will be useful for corroborating the potential clinical interest of breast fluid protein analysis.
1 Supported by Grants PB87-1045 and SAL91-0617 from the Comision Interministerial de Ciencia y Tecnologia (CICYT)-Spain and a fellowship from the Fundacion para la Investigacion Cientifica Aplicada y la Tecnologia (FICYT), Asturias, Spain (L. M. S.).
2 To whom requests for reprints should be addressed.
Received 7/18/91. Accepted 10/22/91.
This article has been cited by other articles:
|
|
 |
|
  Md. I. Hassan, A. Waheed, S. Yadav, T. P. Singh, and F. Ahmad Zinc {alpha}2-Glycoprotein: A Multidisciplinary Protein Mol. Cancer Res., June 1, 2008; 6(6): 892 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. P. Bondar, D. R. Barnidge, E. W. Klee, B. J. Davis, and G. G. Klee LC-MS/MS Quantification of Zn-{alpha}2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer Clin. Chem., April 1, 2007; 53(4): 673 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Vitek Impact of Serum Bilirubin on Human Diseases Pediatrics, May 1, 2005; 115(5): 1411 - 1412. [Full Text] [PDF]
|
|
|
|
|
|
F. Mannello and M. Sebastiani Zymographic Analyses and Measurement of Matrix Metalloproteinase-2 and -9 in Nipple Aspirate Fluids Clin. Chem., September 1, 2003; 49(9): 1546 - 1550. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Carsol, S. Gingras, and J. Simard Synergistic Action of Prolactin (PRL) and Androgen on PRL-Inducible Protein Gene Expression in Human Breast Cancer Cells: A Unique Model for Functional Cooperation between Signal Transducer and Activator of Transcription-5 and Androgen Receptor Mol. Endocrinol., July 1, 2002; 16(7): 1696 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Vizoso, E. Plaza, J. Vazquez, C. Serra, M. L. Lamelas, L. O. Gonzalez, A. M. Merino, and J. Mendez Lysozyme Expression by Breast Carcinomas, Correlation With Clinicopathologic Parameters, and Prognostic Significance Ann. Surg. Oncol., September 1, 2001; 8(8): 667 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mannello, M. Malatesta, M. Sebastiani, S. Battistelli, and G. Gazzanelli Molecular Forms and Ultrastructural Localization of Prostate-specific Antigen in Nipple Aspirate Fluids, Clin. Chem., December 1, 1999; 45(12): 2263 - 2266. [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Hargreaves, C. S. Potten, C. Harding, L. E. Shaw, M. S. Morton, S. A. Roberts, A. Howell, and N. J. Bundred Two-Week Dietary Soy Supplementation Has an Estrogenic Effect on Normal Premenopausal Breast J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4017 - 4024. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. M. Sánchez, A. J. Chirino, and P. J. Bjorkman Crystal Structure of Human ZAG, a Fat-Depleting Factor Related to MHC Molecules Science, March 19, 1999; 283(5409): 1914 - 1919. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Sanchez, C. Lopez-Otin, and P. J. Bjorkman Biochemical characterization and crystalization of human Zn-alpha 2-glycoprotein, a soluble class I major histocompatibility complex homolog PNAS, April 29, 1997; 94(9): 4626 - 4630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Lopez-Boado, M. Klaus, M. I. Dawson, and C. Lopez-Otin Retinoic Acid-induced Expression of Apolipoprotein D and Concomitant Growth Arrest in Human Breast Cancer Cells Are Mediated through a Retinoic Acid Receptor RARalpha -dependent Signaling Pathway J. Biol. Chem., December 13, 1996; 271(50): 32105 - 32111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Balbin and C. Lopez-Otin Hormonal Regulation of the Human Pepsinogen C Gene in Breast Cancer Cells. IDENTIFICATION OF A CIS-ACTING ELEMENT MEDIATING ITS INDUCTION BY ANDROGENS, GLUCOCORTICOIDS, AND PROGESTERONE J. Biol. Chem., June 21, 1996; 271(25): 15175 - 15181. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
